Destiny Pharma

(DEST)
Sector: Pharmaceuticals & Biotechnology
3.00p
-1.00p -25.00
Last updated: 16:57:06

Director dealings

Trade date Director Volume / Price Trade value Trade type
02/08/2024 Nigel Rudd 1,240,000 @ 250.00p £3,100,000.00 Buy
29/09/2023 William Love 2,300,000 @ 0.00 0.00 Transfer To
26/05/2023 Nick Rodgers 20,000 @ 30.19p £6,038.00 Buy
25/05/2023 Aled Williams 50,000 @ 31.00p £15,500.00 Buy
25/05/2023 Aled Williams 50,000 @ 31.00p £15,500.00 Buy
25/05/2023 Debra Barker 20,000 @ 33.00p £6,600.00 Buy
25/05/2023 Nick Rodgers 49,477 @ 31.00p £15,337.87 Buy
25/05/2023 Nick Rodgers 14,780 @ 30.35p £4,485.73 Buy
27/02/2023 Nick Rodgers 20,000 @ 33.94p £6,788.00 Buy
27/09/2021 Nick Rodgers 2,100 @ 119.80p £2,515.80 Buy
29/04/2021 Nick Rodgers 1,511 @ 148.70p £2,246.86 Buy
22/04/2021 Nick Rodgers 5,000 @ 158.00p £7,900.00 Buy
06/01/2021 Nick Rodgers 9,000 @ 88.00p £7,920.00 Buy
04/06/2018 Nigel Rudd 35,800 @ 110.04p £39,394.32 Buy
04/06/2018 Nigel Rudd 39,100 @ 110.04p £43,025.64 Buy
04/09/2017 Peter Morgan 0 @ 0.00 0.00 Notification of Holding
04/09/2017 Nigel Rudd 0 @ 0.00 0.00 Notification of Holding
04/09/2017 Joe Eagle 0 @ 0.00 0.00 Notification of Holding
04/09/2017 William Love 0 @ 0.00 0.00 Notification of Holding

Director shareholdings

Name Holding Percent
William Love 6,509,500 6.00%
Nigel Rudd 1,240,000 3.00%
Debra Barker 88,461 0.00%
Aled Williams 50,000 0.00%

Major shareholders

Institution name Holding Percent
The Wade Family 5,946,500 14.67%
Hargreave Hale Limited 4,877,070 11.71%
Unicorn Asset Management Limited 4,076,923 4.65%
Rosetta Capital V GP Limited 3,089,971 7.62%
Canaccord Genuity Group Inc 2,995,690 4.09%
Nigel Rudd 1,921,716 3.21%
A&B (HK) Company Ltd 1,910,828 4.71%
CMS Medical Venture Investment Limited 1,910,828 4.39%
Rock (Nominees) Ltd 1,542,500 3.81%